相似文献
1
Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys.
Vaccine. 2012 Jan 11;30(3):506-9. doi: 10.1016/j.vaccine.2011.11.079. Epub 2011 Nov 29.
2
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
J Infect Dis. 2016 Feb 15;213(4):541-50. doi: 10.1093/infdis/jiv496. Epub 2015 Oct 15.
3
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00730-17. Print 2017 Sep 15.
4
Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeys.
J Virol. 2012 Nov;86(21):11434-40. doi: 10.1128/JVI.01779-12. Epub 2012 Aug 15.
5
Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance.
J Virol. 2015 Jan 15;89(2):1195-204. doi: 10.1128/JVI.02370-14. Epub 2014 Nov 5.
6
DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses.
Vaccine. 2018 Jul 25;36(31):4621-4632. doi: 10.1016/j.vaccine.2018.06.047. Epub 2018 Jun 28.
7
Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
Vaccine. 2008 Nov 11;26(48):6124-31. doi: 10.1016/j.vaccine.2008.09.017. Epub 2008 Sep 22.
8
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
J Transl Med. 2019 May 24;17(1):175. doi: 10.1186/s12967-019-1924-1.
9
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.
Nat Med. 2010 Mar;16(3):319-23. doi: 10.1038/nm.2089. Epub 2010 Feb 21.
10
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
J Virol. 2016 Mar 28;90(8):4133-4149. doi: 10.1128/JVI.03135-15. Print 2016 Apr.
引用本文的文献
1
The use of adenoviral vectors in gene therapy and vaccine approaches.
Genet Mol Biol. 2022 Oct 7;45(3 Suppl 1):e20220079. doi: 10.1590/1678-4685-GMB-2022-0079. eCollection 2022.
2
Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA Virus.
Vaccines (Basel). 2019 Jun 29;7(3):57. doi: 10.3390/vaccines7030057.
3
Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.
Hum Vaccin Immunother. 2018;14(9):2163-2177. doi: 10.1080/21645515.2018.1489949. Epub 2018 Jul 12.
4
Virus-Like-Vaccines against HIV.
Vaccines (Basel). 2018 Feb 11;6(1):10. doi: 10.3390/vaccines6010010.
5
Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.
J Transl Med. 2016 Dec 20;14(1):343. doi: 10.1186/s12967-016-1102-7.
6
DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
J Immunol. 2016 Nov 15;197(10):3999-4013. doi: 10.4049/jimmunol.1600697. Epub 2016 Oct 12.
7
HIV DNA Vaccine: Stepwise Improvements Make a Difference.
Vaccines (Basel). 2014 May 14;2(2):354-79. doi: 10.3390/vaccines2020354.
8
HIV-1 conserved elements p24CE DNA vaccine induces humoral immune responses with broad epitope recognition in macaques.
PLoS One. 2014 Oct 22;9(10):e111085. doi: 10.1371/journal.pone.0111085. eCollection 2014.
9
HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.
PLoS One. 2014 Feb 28;9(2):e90100. doi: 10.1371/journal.pone.0090100. eCollection 2014.
10
Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.
PLoS One. 2014 Jan 23;9(1):e86254. doi: 10.1371/journal.pone.0086254. eCollection 2014.
本文引用的文献
1
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.
2
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection.
Nature. 2010 May 20;465(7296):350-4. doi: 10.1038/nature08997. Epub 2010 May 5.
3
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.
Nat Med. 2010 Mar;16(3):319-23. doi: 10.1038/nm.2089. Epub 2010 Feb 21.
4
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.
Lancet. 2008 Nov 29;372(9653):1894-1905. doi: 10.1016/S0140-6736(08)61592-5. Epub 2008 Nov 13.
5
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.
Nature. 2009 Jan 1;457(7225):87-91. doi: 10.1038/nature07469. Epub 2008 Nov 9.
6
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys.
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10489-94. doi: 10.1073/pnas.0803352105. Epub 2008 Jul 23.
7
Towards prediction of degenerate CTL epitope recognition.
Hum Vaccin. 2008 Mar-Apr;4(2):115-21. doi: 10.4161/hv.4.2.5215. Epub 2007 Oct 26.
8
The molecular basis for public T-cell responses?
Nat Rev Immunol. 2008 Mar;8(3):231-8. doi: 10.1038/nri2260.
9
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.
J Virol. 2007 May;81(9):4654-63. doi: 10.1128/JVI.02696-06. Epub 2007 Feb 28.
10
HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features.
Curr HIV Res. 2007 Jan;5(1):97-107. doi: 10.2174/157016207779316260.
Zotero 插件